Publications
- Monoclonal antibodies in the treatment of non-small cell lung carcinoma2017 | Publication without faculty affiliation
- Immunotherapy in treatment of lung cancer2016 | Publication without faculty affiliation
- Pembrolizumab in the treatment of non-small-cell lung cancer2016 | Publication without faculty affiliation
- Immunotherapy in lung cancer treatment2016 | Publication without faculty affiliation
- Nivolumab in treatment of NSCLC2016 | Publication without faculty affiliation
- Immunotherapy of pulmonary carcinoma2015 | Publication without faculty affiliation
- Immunotherapy of bronchogenic carcinoma and its perspectives2015 | Publication without faculty affiliation
- Immunotherapy in lung cancer2014 | Publication without faculty affiliation
- Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer2023 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
Loading network view...